Sign in
Neovascular AMD with marked macular fluid and rapid response to anti-VEGF therapy
Journal article   Peer reviewed

Neovascular AMD with marked macular fluid and rapid response to anti-VEGF therapy

Edward Wood, Jonathan S Chang, Harry W Flynn, Jr and John W Kitchens
Ophthalmic surgery, lasers & imaging retina, Vol.45(2), pp.175-178
2014-03
PMID: 24512809

Abstract

Antibodies, Monoclonal, Humanized - therapeutic use Intravitreal Injections Tomography, Optical Coherence Humans Male Treatment Outcome Wet Macular Degeneration - physiopathology Vascular Endothelial Growth Factor A - antagonists & inhibitors Bevacizumab Wet Macular Degeneration - diagnosis Wet Macular Degeneration - drug therapy Ranibizumab Subretinal Fluid Aged, 80 and over Angiogenesis Inhibitors - therapeutic use Female Aged Visual Acuity - physiology

Metrics

9 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.36 Ophthalmology
1.36.383 Diabetic Retinopathy
Web Of Science research areas
Ophthalmology
Surgery
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details